201 related articles for article (PubMed ID: 8771659)
1. [The antagonist of type-II serotonin receptors naftidrofuryl in the treatment of patients with intermittent claudication].
Komarov AL; Panchenko EP; Eshkeeva AR; Dobrovol'skiĭ AB; Titaeva EV; Karpov IuA
Ter Arkh; 1996; 68(2):49-53. PubMed ID: 8771659
[TBL] [Abstract][Full Text] [Related]
2. Authors' reply: systematic review of the efficacy of cilostazol, naftidrofuryl oxalate and pentoxifylline for the treatment of intermittent claudication (Br J Surg 2012; 99: 1630-1638).
Stevens JW; Simpson E; Harnan S; Squires H; Meng Y; Thomas S; Michaels J; Stansby G
Br J Surg; 2013 Dec; 100(13):1838-9. PubMed ID: 24227373
[No Abstract] [Full Text] [Related]
3. Treatment of stage II chronic arterial disease of the lower limbs with the serotonergic antagonist naftidrofuryl: results after 6 months of a controlled, multicenter study.
Adhoute G; Andreassian B; Boccalon H; Cloarec M; Di Maria G; Lefebvre O; Mondine P; Plagnol P; Pointel JP; Quancard X
J Cardiovasc Pharmacol; 1990; 16 Suppl 3():S75-80. PubMed ID: 1369725
[TBL] [Abstract][Full Text] [Related]
4. Naftidrofuryl: a review of its use in the treatment of intermittent claudication.
Goldsmith DR; Wellington K
Drugs Aging; 2005; 22(11):967-77. PubMed ID: 16323973
[TBL] [Abstract][Full Text] [Related]
5. Systematic review of the efficacy of cilostazol, naftidrofuryl oxalate and pentoxifylline for the treatment of intermittent claudication (Br J Surg 2012; 99: 1630-1638).
Roset PN
Br J Surg; 2013 Dec; 100(13):1838. PubMed ID: 24227374
[No Abstract] [Full Text] [Related]
6. Cost effectiveness of cilostazol compared with naftidrofuryl and pentoxifylline in the treatment of intermittent claudication in the UK.
Guest JF; Davie AM; Clegg JP
Curr Med Res Opin; 2005 Jun; 21(6):817-26. PubMed ID: 15969881
[TBL] [Abstract][Full Text] [Related]
7. Cost-effectiveness of cilostazol, naftidrofuryl oxalate, and pentoxifylline for the treatment of intermittent claudication in people with peripheral arterial disease.
Meng Y; Squires H; Stevens JW; Simpson E; Harnan S; Thomas S; Michaels J; Stansby G; O'Donnell ME
Angiology; 2014 Mar; 65(3):190-7. PubMed ID: 23378195
[TBL] [Abstract][Full Text] [Related]
8. Drug treatment of claudication: vasodilators, hemorrheologic agents, and antiserotonin drugs.
Taylor LM; Porter JM
J Vasc Surg; 1986 Feb; 3(2):374-81. PubMed ID: 2935646
[No Abstract] [Full Text] [Related]
9. Systematic review of the efficacy of cilostazol, naftidrofuryl oxalate and pentoxifylline for the treatment of intermittent claudication.
Stevens JW; Simpson E; Harnan S; Squires H; Meng Y; Thomas S; Michaels J; Stansby G
Br J Surg; 2012 Dec; 99(12):1630-8. PubMed ID: 23034699
[TBL] [Abstract][Full Text] [Related]
10. Findings of the Naftidrofuryl in Quality of Life (NIQOL) European study program.
Spengel F; Clément D; Boccalon H; Liard F; Brown T; Lehert P
Int Angiol; 2002 Mar; 21(1):20-7. PubMed ID: 11941270
[TBL] [Abstract][Full Text] [Related]
11. [Evaluation of the efficacy and tolerance of naftidrofuryl in patients presenting with exertional angina. Multicenter double-blind versus placebo study].
Hirsch JL; Bensoussan JJ; Mosnier M; Lehert P
Ann Cardiol Angeiol (Paris); 1999 Feb; 48(2):137-45. PubMed ID: 12555338
[TBL] [Abstract][Full Text] [Related]
12. Naftidrofuryl in quality of life (NIQOL). A Belgian study.
D'Hooge D; Lehert P; Clement DL
Int Angiol; 2001 Dec; 20(4):288-94. PubMed ID: 11782694
[TBL] [Abstract][Full Text] [Related]
13. New treatment options in intermittent claudication: the US experience.
Hiatt WR
Int J Clin Pract Suppl; 2001 Apr; (119):20-7. PubMed ID: 11355276
[TBL] [Abstract][Full Text] [Related]
14. Peripheral vasodilators versus pentoxifylline for the treatment of intermittent claudication.
Aviado DM
Ric Clin Lab; 1983; 13 Suppl 3():263-8. PubMed ID: 6143383
[TBL] [Abstract][Full Text] [Related]
15. A new study demonstrates the efficacy of naftidrofuryl in the treatment of intermittent claudication. Findings of the Naftidrofuryl Clinical Ischemia Study (NCIS).
Kieffer E; Bahnini A; Mouren X; Gamand S
Int Angiol; 2001 Mar; 20(1):58-65. PubMed ID: 11342997
[TBL] [Abstract][Full Text] [Related]
16. [Naftidrofuryl in the therapy of chronic arterial occlusive disease in the intermittent claudication stage].
Valentin A; Karnik R; Stöllberger C; Slany J
Vasa Suppl; 1987; 20():361-4. PubMed ID: 3321493
[No Abstract] [Full Text] [Related]
17. Can claudication be improved with medication?
Conners MS; Money SR
Semin Vasc Surg; 2002 Dec; 15(4):237-44. PubMed ID: 12478498
[TBL] [Abstract][Full Text] [Related]
18. A randomized trial of iloprost in patients with intermittent claudication.
Creager MA; Pande RL; Hiatt WR
Vasc Med; 2008 Feb; 13(1):5-13. PubMed ID: 18372433
[TBL] [Abstract][Full Text] [Related]
19. [Evidence-based therapy of intermittent claudication].
Krankenpfl J; 2004; 42(5-6):184. PubMed ID: 15527244
[No Abstract] [Full Text] [Related]
20. [Clinical effectiveness of naftidrofuryl in intermittent claudication].
Kriessmann A; Neiss A
Vasa Suppl; 1988; 24():27-32. PubMed ID: 3062823
[No Abstract] [Full Text] [Related]
[Next] [New Search]
